Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.29
-0.45 (-7.84%)
At close: May 30, 2025, 4:00 PM
5.27
-0.02 (-0.38%)
After-hours: May 30, 2025, 7:57 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $32.35 million as of May 30, 2025. Its market cap has decreased by -40.11% in one year.
Market Cap
32.35M
Enterprise Value
-97.64M
1-Year Change
-40.11%
Ranking
Category
Stock Price
$5.29
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $32.35M, a decrease of -94.15%. That is a compound annual growth rate of -45.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 32.35M | -78.12% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |